A distinct serum protein pattern in patients with paranoid schizophrenia; Physiology and Pharmacology; Vol. 21, iss. 4

מידע ביבליוגרפי
Parent link:Physiology and Pharmacology
Vol. 21, iss. 4.— 2017.— [P. 304-311]
מחבר תאגידי: Национальный исследовательский Томский политехнический университет Инженерная школа неразрушающего контроля и безопасности Отделение контроля и диагностики
מחברים אחרים: Alekseeva I. V., Timofeyeva N. A., Ivanova S. A. Svetlana Aleksandrovna, Simutkin G. G., Semke A. V., Losenkov I. S., Bokhan N., Fedorova O. S., Chernonosov A. A.
סיכום:Title screen
Introduction: Schizophrenia is a chronic mental illness, whose aetiology is still unclear; therefore, information about differences in serum protein patterns may improve the understanding of the pathophysiology of schizophrenia. The goal of this study was to use the proteomic approach to identify altered protein levels in the serum samples from patients with schizophrenia. Methods: Blood was collected from 10 patients with paranoid schizophrenia and 10 healthy volunteers matched by sex and age. Serum proteins were isolated by 2D gel electrophoresis. Proteins with altered levels were identified by matrix-assisted laser desorption ionisation time-of-flight mass spectrometry. Results: We uncovered major changes in the expression of such proteins as apolipoproteins of classes A4 and C3, transthyretin (TTR) and serum amyloid A1. An increase in expression was found only for apolipoprotein A4, whereas the expression of apolipoprotein C3, TTR and serum amyloid A1 was decreased. The observed differences in the expression of serum proteins (TTR and serum amyloid) are in good agreement with the results obtained by other research groups during analyses of cerebrospinal fluid or post-mortem brain tissues by other methods. Conclusion: Such alterations of the expression of these proteins may indicate problems with regulation, for example, in the synthesis. On the other hand, the altered protein expression may simply reflect the pathophysiological status of patients, where these proteins could be candidates for biomarkers. Further research is needed to confirm the significance of the altered levels of these proteins in the pathogenesis of schizophrenia and to determine their suitability as biomarkers of schizophrenia.
שפה:אנגלית
יצא לאור: 2017
נושאים:
גישה מקוונת:http://phypha.ir/ppj/article-1-1287-en.html
פורמט: אלקטרוני Book Chapter
KOHA link:https://koha.lib.tpu.ru/cgi-bin/koha/opac-detail.pl?biblionumber=658070

MARC

LEADER 00000naa0a2200000 4500
001 658070
005 20250127153451.0
035 |a (RuTPU)RU\TPU\network\25143 
090 |a 658070 
100 |a 20180515d2017 k||y0engy50 ba 
101 0 |a eng 
102 |a IR 
135 |a drcn ---uucaa 
181 0 |a i  
182 0 |a b 
200 1 |a A distinct serum protein pattern in patients with paranoid schizophrenia  |f I. V. Alekseeva [et al.] 
203 |a Text  |c electronic 
300 |a Title screen 
320 |a [References: p. 310-311 (29 tit.)] 
330 |a Introduction: Schizophrenia is a chronic mental illness, whose aetiology is still unclear; therefore, information about differences in serum protein patterns may improve the understanding of the pathophysiology of schizophrenia. The goal of this study was to use the proteomic approach to identify altered protein levels in the serum samples from patients with schizophrenia. Methods: Blood was collected from 10 patients with paranoid schizophrenia and 10 healthy volunteers matched by sex and age. Serum proteins were isolated by 2D gel electrophoresis. Proteins with altered levels were identified by matrix-assisted laser desorption ionisation time-of-flight mass spectrometry. Results: We uncovered major changes in the expression of such proteins as apolipoproteins of classes A4 and C3, transthyretin (TTR) and serum amyloid A1. An increase in expression was found only for apolipoprotein A4, whereas the expression of apolipoprotein C3, TTR and serum amyloid A1 was decreased. The observed differences in the expression of serum proteins (TTR and serum amyloid) are in good agreement with the results obtained by other research groups during analyses of cerebrospinal fluid or post-mortem brain tissues by other methods. Conclusion: Such alterations of the expression of these proteins may indicate problems with regulation, for example, in the synthesis. On the other hand, the altered protein expression may simply reflect the pathophysiological status of patients, where these proteins could be candidates for biomarkers. Further research is needed to confirm the significance of the altered levels of these proteins in the pathogenesis of schizophrenia and to determine their suitability as biomarkers of schizophrenia. 
461 |t Physiology and Pharmacology 
463 |t Vol. 21, iss. 4  |v [P. 304-311]  |d 2017 
610 1 |a электронный ресурс 
610 1 |a труды учёных ТПУ 
610 1 |a шизофрения 
610 1 |a психическое состояние 
610 1 |a расстройства 
610 1 |a протеомика 
610 1 |a биомаркеры 
701 1 |a Alekseeva  |b I. V. 
701 1 |a Timofeyeva  |b N. A. 
701 1 |a Ivanova  |b S. A.  |c specialist in the field of ecology and life safety  |c Professor of Tomsk Polytechnic University, doctor of medical sciences  |f 1964-  |g Svetlana Aleksandrovna  |3 (RuTPU)RU\TPU\pers\33859 
701 1 |a Simutkin  |b G. G. 
701 1 |a Semke  |b A. V. 
701 1 |a Losenkov  |b I. S. 
701 1 |a Bokhan  |b N. 
701 1 |a Fedorova  |b O. S. 
701 1 |a Chernonosov  |b A. A. 
712 0 2 |a Национальный исследовательский Томский политехнический университет  |b Инженерная школа неразрушающего контроля и безопасности  |b Отделение контроля и диагностики  |3 (RuTPU)RU\TPU\col\23584 
801 2 |a RU  |b 63413507  |c 20180515  |g RCR 
856 4 |u http://phypha.ir/ppj/article-1-1287-en.html 
942 |c CF